Xinhua
20 Jan 2021, 01:35 GMT+10
BAGHDAD, Jan. 19 (Xinhua) -- Iraq on Tuesday approved the emergency use of China's Sinopharm and British AstraZeneca vaccines to contain the spread of COVID-19 pandemic.
The Iraqi Ministry of Health said in a brief statement that the Iraqi National Board for Selection of Drugs (NBSD) approved the emergency use of the two vaccines.
Health Minister Hassan al-Tamimi, who held a meeting in his office with the NBSD, said that the ministry has made all logistical preparations to receive the vaccines and has identified the groups that would take the vaccines, the ministry said in a separate statement.
Iraqi Ministry of Health spokesman Sayf al-Badr told Xinhua that the Chinese vaccine, developed by China National Pharmaceutical Group (Sinopharm), "conforms to the NBSD standards, and therefore the Iraqi state approved it for use inside Iraq."
Previously, the NBSD already approved the emergency use of Pfizer-BioNTech vaccine to combat the pandemic.
Also in the day, the Ministry of Health reported 823 new COVID-19 cases, bringing the total nationwide infections to 609,852.
The ministry also reported nine new deaths, raising the death toll from the infectious virus to 12,962, and 1,813 more recovered cases, bringing the total recoveries to 573,011.
China has been helping Iraq fight the COVID-19 pandemic.
From March 7 to April 26 in 2020, a Chinese team of seven medical experts spent 50 days in Iraq to help contain the disease, during which they helped build a PCR lab and install an advanced CT scanner in the capital Baghdad.
China has also sent three batches of medical aid to Iraq.
Get a daily dose of China National News news through our daily email, its complimentary and keeps you fully up to date with world and business news as well.
Publish news of your business, community or sports group, personnel appointments, major event and more by submitting a news release to China National News.
More InformationNEW YORK, New York - U.S. stock markets rose Tuesday as investors and traders anticipated a positive outcome from ongoing trade talks...
BEIJING/WASHINGTON, D.C.: In a rare move aimed at easing mounting supply chain pressure, China has issued temporary export licenses...
BERN, Switzerland: UBS faces a sweeping new capital requirement from the Swiss government, which this week proposed changes that could...
NEW YORK CITY, New York: At a Walmart Supercenter in New Jersey, buttercream borders and edible-ink cartoons aren't just about sweet...
NEW YORK, New York - Wall Street delivered a split performance on Monday, with the Nasdaq Composite notching up gains while the Dow...
NEW YORK CITY, New York: Luxury group Kering is in exclusive discussions to sell a stake in its prime New York real estate asset on...
BEIJING/WASHINGTON, D.C.: In a rare move aimed at easing mounting supply chain pressure, China has issued temporary export licenses...
TOKYO, Japan: Japan's hopes for a foothold in commercial lunar exploration suffered a second blow this week after Tokyo-based startup...
SYDNEY, Australia: Australia will not ease its strict biosecurity rules during trade talks with the United States, Prime Minister Anthony...
TOKYO, Japan: Japan's demographic challenges intensified in 2024, with the number of births falling to another all-time low—underscoring...
BEIJING, China: A little-known office inside China's Ministry of Commerce has become a powerful chokepoint in the global auto and tech...
BERLIN/FRANKFURT: Some car parts factories in Europe have stopped production, and companies like Mercedes-Benz are making backup plans...